Author:
Furtwängler Rhoikos,Graf Norbert
Publisher
Springer Berlin Heidelberg
Reference17 articles.
1. Anupindi SA, Bedoya MA, Lindell RB, Rambhatla SJ, Zelley K, Nicholas KE, Chauvin NA (2015) Diagnostic performance of whole-body MRI as a tool for cancer screening in children with genetic cancer-predisposing conditions. AJR 205:400–408.
https://doi.org/10.2214/AJR.14.13663
2. Armstrong GT, Liu Q, Neglia JP, Leisenring W, Robison LL, Mertens AC (2009) Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 27:2328–2338.
https://doi.org/10.1200/JCO.2008.21.1425
3. Gefenas E, Cekanauskaite A, Lekstutiene J, Lukaseviciene V (2017) Application challenges of the new EU Clinical Trials Regulation. J Clin Pharmacol 73:795–798.
https://doi.org/10.1007/s00228-017-2267-6
4. Glickman ME, van Dyk DA (2007) Basic Bayesian methods. Methods Mol Biol 404:319–338.
https://doi.org/10.1007/978-1-59745-530-5_16
5. Kaatsch P, Grabow D, Spix C (2016) German Childhood Cancer Registry – annual report 2016 (1980–2015). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz